Evidence map›Paper›PMID 31724066›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2020

Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases.

Nguyen Hoai Nguyen, Gia-Buu Tran, Cuong Thach Nguyen

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06554496 (Obstructive Sleep Apnea Severity and Xanthine Oxidoreductase Activity), which is not on this map. Cited by 75 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06554496 narecruitingnot on this mapstarted 2024, after this paper: background citation

Obstructive Sleep Apnea Severity and Xanthine Oxidoreductase Activity: Mechanisms and Clinical Implications

TypeinterventionalSponsorNanjing Medical UniversityRan2024 to 2025Enrolled80ConditionsObstructive Sleep ApneaArmsCPAP Treatment
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Molecular Hydrogen in the Treatment of Respiratory Diseases.International journal of molecular sciences · 2025
    Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Nguyen Hoai NguyenFaculty of Biotechnology, Ho Chi Minh City Open University, 97 Vo Van Tan Street, District 3, Ho Chi Minh City, Vietnam.
Gia-Buu TranDepartment of Biotechnology, Institute of Biotechnology and Food-technology, Industrial University of Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Cuong Thach NguyenNTT Hi-Tech Institute, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam. ctnguyen.ntt@gmail.com.ORCID 0000-0002-1894-3811
Ho Chi Minh City Open University · VNIndustrial University of Ho Chi Minh City · VNTrường ĐH Nguyễn Tất Thành · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Free radicals and other oxidants are critical determinants of the cellular signaling pathways involved in the pathogenesis of several human diseases including inflammatory diseases. Numerous studies have demonstrated the protective effects of antioxidant enzymes during inflammation by elimination of free radicals. The superoxide dismutase (SOD), an antioxidant enzyme, plays an essential pathogenic role in the inflammatory diseases by not only catalyzing the conversion of the superoxide to hydrogen peroxide and oxygen but also affecting immune responses. There are three distinct isoforms of SOD, which distribute in different cellular compartments such as cytosolic SOD1, mitochondrial SOD2, and extracellular SOD3. Many studies have investigated the anti-oxidative effects of SOD3 in the inflammatory diseases. Herein, in this review, we focus on the current understanding of SOD3 as a therapeutic protein in inflammatory diseases such as skin, autoimmune, lung, and cardiovascular inflammatory diseases. Moreover, the mechanism(s) by which SOD3 modulates immune responses and signal initiation in the pathogenesis of the diseases will be further discussed.

Indexed as

AnimalsAntioxidantsArthritisDiabetes ComplicationsHumansInflammationIsoenzymesLung DiseasesOxidative StressPhylogenyReactive Oxygen SpeciesSkin DiseasesSuperoxide DismutaseAntioxidantsIsoenzymesReactive Oxygen SpeciesSOD3 protein, humanSuperoxide DismutaseAnti-oxidativeAutoimmune diseasesExtracellular superoxide dismutase (SOD3)Skin inflammationTherapeutic protein

Identifiers

PMID31724066
OpenAlexW2986273937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.